Helen Kindelan
Physician Assistant · Plantation, FLNPI 1902358211
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.0% of the total across 97 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 25 manufacturers reported payments, led by Stryker at 26.1% of the total. Reporting peaked in 2021 at $766 and has fallen 74.4% since, to $196 in 2024.
Across 97 payments — averaging $20.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$513
- Teva Pharmaceuticals USA, Inc.$348
- AbbVie$109
- Argenx US, Inc.$103
- UCB, Inc.$102
- Octapharma USA, Inc.$94
- plus $694 from 19 others
What the payments were for
- Speaking & faculty fees$392%
- Food & beverage$1,92598%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 22 | $513 |
| Teva Pharmaceuticals USA, Inc. | 17 | $348 |
| AbbVie | 8 | $109 |
| Argenx US, Inc. | 4 | $103 |
| UCB, Inc. | 4 | $102 |
| Octapharma USA, Inc. | 6 | $94 |
| Biohaven Pharmaceuticals, Inc. | 5 | $80 |
| SK Life Science, Inc. | 3 | $71 |
| AstraZeneca | 2 | $55 |
| Lilly USA, LLC | 3 | $53 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $43 |
| Lundbeck LLC | 2 | $42 |
| Jazz Pharmaceuticals Inc. | 2 | $41 |
| Acorda Therapeutics, Inc | 2 | $39 |
| Merz Pharmaceuticals, LLC | 1 | $38 |
| Sunovion Pharmaceuticals Inc. | 2 | $34 |
| Banner Life Sciences, LLC | 2 | $34 |
| Neurocrine Biosciences, Inc. | 2 | $31 |
| Biogen | 2 | $26 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $21 |
| Neurelis, Inc. | 1 | $20 |
| Avion Pharmaceuticals | 1 | $19 |
| Aquestive Therapeutics, Inc. | 1 | $17 |
| Aprecia Pharmaceuticals, LLC | 1 | $16 |
| Amgen | 1 | $14 |
How this compares
$1,964 in reported general payments places this provider in the 75th percentile of 8,062 physician assistant providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 18 | $26,206 |
| Celecoxib | 21 | $659 |
| Methocarbamol | 24 | $134 |
| Pregabalin | 12 | $104 |
| Tramadol Hcl | 12 | $16 |
Paid to pharmacies, not to this prescriber.
Other physician assistant in Plantation
- Audrey BeckerSt Augustine$689K
- Kevin WilliamsTampa$647K
- Brian BonomoLecanto$559K
- Melissa SingletonOcala$482K
- Reeli ReinuMaitland$427K
- Jeanelle KingMiami$424K
- Risha BellomoOrlando$397K
- Jason BergerClearwater$344K
- Ashley MillerGainesville$328K
- Nicole HillOrlando$319K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.